Changchun High-Tech Industry (Group) Co Ltd
Company Profile
Business description
Changchun High-Tech Industry (Group) Co Ltd is engaged in the production and sales of biopharmaceuticals, Chinese patent medicine production, and real estate development. The company operates its business through three segments. The Pharmaceuticals segment focuses on the research and development, manufacturing, and sales of genetically engineered biologics, human vaccines, traditional Chinese medicines, and chemical pharmaceuticals. The Real Estate segment is involved in property development and sales. The Services segment provides scientific research and technical support, along with leasing and various business-related services. It generates the majority of its revenue from the Pharmaceuticals segment.
Contact
Intersection of Zhenyu Street and Dongweishan Road
27th Floor, Building B, Hi-Tech Hairong Plaza
Jilin Province
Changchun130012
CHNT: +86 43180557027
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
11,547
Stocks News & Analysis
stocks
Strong result for ASX insurer but not the new norm
stocks
Eli Lilly earnings: Weak Orforglipron obesity data weighs down a strong quarter
stocks
Solid 2025 for A-REIT but development activity will weigh on 2026
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,117.60 | 41.00 | 0.45% |
CAC 40 | 7,707.94 | 35.06 | -0.45% |
DAX 40 | 24,067.82 | 95.04 | -0.39% |
Dow JONES (US) | 44,175.61 | 206.97 | 0.47% |
FTSE 100 | 9,112.50 | 16.77 | 0.18% |
HKSE | 24,906.81 | 47.99 | 0.19% |
NASDAQ | 21,450.02 | 207.32 | 0.98% |
Nikkei 225 | 41,820.48 | 761.33 | 1.85% |
NZX 50 Index | 12,911.86 | 67.23 | 0.52% |
S&P 500 | 6,389.45 | 49.45 | 0.78% |
S&P/ASX 200 | 8,844.80 | 37.70 | 0.43% |
SSE Composite Index | 3,647.55 | 12.42 | 0.34% |